Aline Andres
Concepts (361)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk, Human | 24 | 2026 | 122 | 7.060 |
Why?
| | Body Composition | 20 | 2026 | 355 | 6.080 |
Why?
| | Adiposity | 12 | 2026 | 147 | 4.440 |
Why?
| | Obesity | 31 | 2026 | 1204 | 4.350 |
Why?
| | Breast Feeding | 27 | 2026 | 203 | 4.050 |
Why?
| | Body Mass Index | 24 | 2026 | 717 | 3.880 |
Why?
| | Pregnancy | 53 | 2026 | 2608 | 3.720 |
Why?
| | Infant Formula | 22 | 2026 | 154 | 3.370 |
Why?
| | Weight Gain | 14 | 2025 | 245 | 2.870 |
Why?
| | Child Development | 13 | 2026 | 215 | 2.560 |
Why?
| | Pregnancy Complications | 13 | 2026 | 406 | 2.490 |
Why?
| | Overweight | 11 | 2024 | 232 | 2.460 |
Why?
| | Milk | 10 | 2026 | 84 | 2.460 |
Why?
| | Exercise | 10 | 2024 | 561 | 2.330 |
Why?
| | Mothers | 8 | 2024 | 269 | 2.290 |
Why?
| | Adipose Tissue | 8 | 2025 | 210 | 2.230 |
Why?
| | Infant | 45 | 2026 | 3805 | 2.220 |
Why?
| | Female | 95 | 2026 | 28782 | 2.190 |
Why?
| | Maternal Exposure | 4 | 2025 | 103 | 2.030 |
Why?
| | Fluorocarbons | 3 | 2025 | 65 | 1.900 |
Why?
| | Longitudinal Studies | 21 | 2026 | 774 | 1.870 |
Why?
| | Maternal Nutritional Physiological Phenomena | 7 | 2025 | 64 | 1.850 |
Why?
| | Environmental Pollutants | 3 | 2025 | 110 | 1.820 |
Why?
| | Humans | 103 | 2026 | 53230 | 1.630 |
Why?
| | Oligosaccharides | 5 | 2024 | 33 | 1.580 |
Why?
| | Breast Milk Expression | 2 | 2023 | 4 | 1.570 |
Why?
| | Infant Nutritional Physiological Phenomena | 9 | 2026 | 62 | 1.520 |
Why?
| | Absorptiometry, Photon | 7 | 2023 | 160 | 1.410 |
Why?
| | Insulin Resistance | 8 | 2021 | 282 | 1.360 |
Why?
| | Diet | 16 | 2025 | 610 | 1.340 |
Why?
| | Adult | 38 | 2026 | 14534 | 1.330 |
Why?
| | Infant, Newborn | 28 | 2026 | 2913 | 1.310 |
Why?
| | Soybean Proteins | 5 | 2026 | 167 | 1.290 |
Why?
| | Placenta | 5 | 2025 | 146 | 1.290 |
Why?
| | Plethysmography | 5 | 2020 | 43 | 1.290 |
Why?
| | Child, Preschool | 19 | 2025 | 4162 | 1.230 |
Why?
| | Follicular Fluid | 2 | 2019 | 9 | 1.120 |
Why?
| | Pregnant Women | 5 | 2022 | 71 | 1.110 |
Why?
| | Cohort Studies | 14 | 2024 | 1557 | 1.090 |
Why?
| | Infant Food | 3 | 2020 | 28 | 1.060 |
Why?
| | Bottle Feeding | 5 | 2020 | 34 | 1.060 |
Why?
| | Male | 47 | 2026 | 27435 | 1.040 |
Why?
| | Exercise Therapy | 2 | 2025 | 105 | 1.020 |
Why?
| | Inflammation | 4 | 2026 | 652 | 0.960 |
Why?
| | Postpartum Period | 4 | 2023 | 111 | 0.960 |
Why?
| | DNA Methylation | 5 | 2025 | 592 | 0.950 |
Why?
| | Fatty Acids, Volatile | 1 | 2026 | 16 | 0.950 |
Why?
| | RNA Stability | 1 | 2026 | 29 | 0.950 |
Why?
| | Puberty | 1 | 2026 | 28 | 0.940 |
Why?
| | Adolescent Development | 1 | 2026 | 26 | 0.940 |
Why?
| | Isoleucine | 2 | 2024 | 27 | 0.930 |
Why?
| | Specimen Handling | 1 | 2026 | 63 | 0.920 |
Why?
| | RNA | 2 | 2026 | 173 | 0.920 |
Why?
| | Fatty Acids | 1 | 2026 | 154 | 0.900 |
Why?
| | Anthropometry | 6 | 2024 | 101 | 0.900 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2020 | 250 | 0.890 |
Why?
| | Metabolome | 3 | 2020 | 107 | 0.850 |
Why?
| | Child | 18 | 2026 | 7379 | 0.850 |
Why?
| | Pregnancy Outcome | 1 | 2025 | 231 | 0.830 |
Why?
| | Lipid Metabolism | 4 | 2019 | 189 | 0.780 |
Why?
| | Growth | 3 | 2020 | 40 | 0.770 |
Why?
| | Eating | 2 | 2021 | 159 | 0.770 |
Why?
| | Prenatal Care | 3 | 2023 | 111 | 0.750 |
Why?
| | Blood Glucose | 3 | 2020 | 490 | 0.750 |
Why?
| | Sleep | 1 | 2023 | 195 | 0.720 |
Why?
| | Pregnancy Trimester, First | 2 | 2023 | 23 | 0.700 |
Why?
| | Homeostasis | 2 | 2020 | 209 | 0.700 |
Why?
| | Monosaccharides | 1 | 2020 | 7 | 0.670 |
Why?
| | Leptin | 3 | 2022 | 151 | 0.670 |
Why?
| | Gestational Age | 6 | 2025 | 394 | 0.650 |
Why?
| | Dietary Proteins | 2 | 2020 | 255 | 0.650 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 51 | 0.650 |
Why?
| | Parents | 2 | 2022 | 341 | 0.640 |
Why?
| | Maternal-Fetal Exchange | 1 | 2020 | 48 | 0.630 |
Why?
| | Isoflavones | 4 | 2009 | 88 | 0.630 |
Why?
| | Lactation | 5 | 2025 | 66 | 0.610 |
Why?
| | Body Weight | 3 | 2021 | 524 | 0.610 |
Why?
| | Early Growth Response Protein 1 | 3 | 2016 | 34 | 0.610 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2026 | 214 | 0.590 |
Why?
| | Fertilization in Vitro | 1 | 2019 | 31 | 0.590 |
Why?
| | Young Adult | 10 | 2025 | 4511 | 0.560 |
Why?
| | Soy Milk | 6 | 2018 | 37 | 0.550 |
Why?
| | Arkansas | 7 | 2025 | 2068 | 0.540 |
Why?
| | Directive Counseling | 1 | 2017 | 23 | 0.510 |
Why?
| | Animals | 20 | 2026 | 13526 | 0.510 |
Why?
| | Antioxidants | 1 | 2019 | 264 | 0.500 |
Why?
| | Oocytes | 1 | 2017 | 95 | 0.500 |
Why?
| | Ovary | 2 | 2016 | 103 | 0.490 |
Why?
| | C-Reactive Protein | 1 | 2017 | 152 | 0.490 |
Why?
| | Triglycerides | 1 | 2017 | 171 | 0.490 |
Why?
| | Prenatal Diagnosis | 1 | 2016 | 94 | 0.480 |
Why?
| | Body Water | 2 | 2012 | 26 | 0.460 |
Why?
| | Patient Compliance | 1 | 2017 | 232 | 0.460 |
Why?
| | Sexual Development | 1 | 2015 | 6 | 0.450 |
Why?
| | Genitalia, Male | 1 | 2015 | 16 | 0.450 |
Why?
| | Behavior Therapy | 1 | 2017 | 185 | 0.450 |
Why?
| | Soy Foods | 1 | 2015 | 20 | 0.450 |
Why?
| | Genitalia, Female | 1 | 2015 | 19 | 0.450 |
Why?
| | Child of Impaired Parents | 1 | 2015 | 43 | 0.440 |
Why?
| | Energy Metabolism | 3 | 2026 | 324 | 0.430 |
Why?
| | Risk Factors | 6 | 2024 | 4017 | 0.430 |
Why?
| | Oxidative Stress | 1 | 2019 | 819 | 0.420 |
Why?
| | Brain | 8 | 2026 | 1350 | 0.420 |
Why?
| | Feces | 3 | 2024 | 159 | 0.390 |
Why?
| | Diet, High-Fat | 4 | 2025 | 243 | 0.380 |
Why?
| | Bone Density | 2 | 2023 | 397 | 0.370 |
Why?
| | Adipogenesis | 3 | 2026 | 54 | 0.370 |
Why?
| | Infant Behavior | 1 | 2012 | 18 | 0.370 |
Why?
| | Depression | 3 | 2026 | 621 | 0.360 |
Why?
| | Epigenesis, Genetic | 2 | 2025 | 412 | 0.350 |
Why?
| | Case-Control Studies | 4 | 2019 | 1212 | 0.340 |
Why?
| | RNA, Ribosomal, 16S | 4 | 2024 | 115 | 0.340 |
Why?
| | Magnetic Resonance Imaging | 4 | 2026 | 1583 | 0.340 |
Why?
| | Electroencephalography | 5 | 2026 | 305 | 0.340 |
Why?
| | Cerebral Cortex | 2 | 2026 | 194 | 0.340 |
Why?
| | Military Personnel | 2 | 2023 | 173 | 0.340 |
Why?
| | Umbilical Cord | 3 | 2017 | 36 | 0.330 |
Why?
| | Insulin | 4 | 2022 | 493 | 0.320 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 1723 | 0.320 |
Why?
| | Feeding Behavior | 2 | 2024 | 195 | 0.320 |
Why?
| | Food Supply | 2 | 2023 | 95 | 0.320 |
Why?
| | Linear Models | 2 | 2021 | 287 | 0.310 |
Why?
| | Phenotype | 3 | 2023 | 803 | 0.310 |
Why?
| | Birth Weight | 4 | 2025 | 119 | 0.310 |
Why?
| | Viruses | 1 | 2009 | 24 | 0.300 |
Why?
| | Virus Diseases | 1 | 2009 | 47 | 0.290 |
Why?
| | Rotavirus | 2 | 2009 | 9 | 0.290 |
Why?
| | MicroRNAs | 2 | 2026 | 397 | 0.290 |
Why?
| | Antiviral Agents | 1 | 2009 | 179 | 0.270 |
Why?
| | Speech Perception | 3 | 2016 | 96 | 0.270 |
Why?
| | Adolescent | 4 | 2026 | 6907 | 0.270 |
Why?
| | Breast | 2 | 2023 | 87 | 0.260 |
Why?
| | Time Factors | 2 | 2026 | 2991 | 0.250 |
Why?
| | Interleukin-8 | 2 | 2024 | 85 | 0.230 |
Why?
| | Pregnancy Trimesters | 1 | 2025 | 13 | 0.230 |
Why?
| | Alkanesulfonic Acids | 1 | 2025 | 11 | 0.230 |
Why?
| | Exercise Test | 1 | 2025 | 137 | 0.220 |
Why?
| | Placentation | 1 | 2025 | 14 | 0.220 |
Why?
| | Polyphenols | 1 | 2025 | 40 | 0.220 |
Why?
| | Resistance Training | 1 | 2025 | 106 | 0.220 |
Why?
| | Heart | 2 | 2020 | 350 | 0.220 |
Why?
| | Diffusion Tensor Imaging | 3 | 2023 | 104 | 0.220 |
Why?
| | Heat-Shock Proteins | 1 | 2025 | 104 | 0.220 |
Why?
| | Temperament | 1 | 2024 | 23 | 0.220 |
Why?
| | Oxygen Consumption | 1 | 2025 | 201 | 0.220 |
Why?
| | Fathers | 1 | 2024 | 27 | 0.210 |
Why?
| | Vagus Nerve | 2 | 2015 | 23 | 0.210 |
Why?
| | Prospective Studies | 5 | 2023 | 2411 | 0.210 |
Why?
| | Evoked Potentials | 2 | 2016 | 67 | 0.210 |
Why?
| | Fast Foods | 1 | 2023 | 10 | 0.200 |
Why?
| | Sodium, Dietary | 1 | 2023 | 24 | 0.200 |
Why?
| | Anxiety | 1 | 2026 | 321 | 0.200 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2021 | 43 | 0.200 |
Why?
| | Immunity, Innate | 1 | 2024 | 112 | 0.200 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2023 | 38 | 0.190 |
Why?
| | Sex Factors | 5 | 2025 | 747 | 0.190 |
Why?
| | Intention | 1 | 2023 | 51 | 0.190 |
Why?
| | Bone Diseases, Metabolic | 1 | 2023 | 79 | 0.190 |
Why?
| | Accelerometry | 1 | 2022 | 14 | 0.190 |
Why?
| | Hypersensitivity | 1 | 2023 | 83 | 0.190 |
Why?
| | Metabolomics | 2 | 2020 | 155 | 0.190 |
Why?
| | Follow-Up Studies | 3 | 2019 | 2318 | 0.190 |
Why?
| | Educational Status | 1 | 2023 | 229 | 0.180 |
Why?
| | Mitochondria | 1 | 2026 | 446 | 0.180 |
Why?
| | Immunoglobulin A | 1 | 2021 | 46 | 0.180 |
Why?
| | Depressive Disorder, Major | 1 | 2023 | 149 | 0.180 |
Why?
| | Lipids | 1 | 2022 | 163 | 0.180 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 90 | 0.180 |
Why?
| | Antibodies, Viral | 1 | 2021 | 109 | 0.170 |
Why?
| | Leucine | 1 | 2021 | 114 | 0.170 |
Why?
| | Predictive Value of Tests | 2 | 2016 | 934 | 0.170 |
Why?
| | Urinalysis | 1 | 2020 | 33 | 0.170 |
Why?
| | Cattle | 3 | 2020 | 207 | 0.160 |
Why?
| | Models, Biological | 2 | 2020 | 737 | 0.160 |
Why?
| | Body Fat Distribution | 1 | 2020 | 10 | 0.160 |
Why?
| | Body Weights and Measures | 1 | 2020 | 17 | 0.160 |
Why?
| | Health Status | 2 | 2020 | 306 | 0.160 |
Why?
| | Health Behavior | 1 | 2022 | 261 | 0.160 |
Why?
| | Physical Conditioning, Animal | 1 | 2020 | 67 | 0.160 |
Why?
| | Transcriptome | 3 | 2018 | 367 | 0.150 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2019 | 141 | 0.150 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 333 | 0.150 |
Why?
| | Diabetes, Gestational | 1 | 2019 | 52 | 0.150 |
Why?
| | Uric Acid | 1 | 2019 | 23 | 0.150 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 501 | 0.150 |
Why?
| | GABAergic Neurons | 1 | 2018 | 10 | 0.150 |
Why?
| | Feasibility Studies | 1 | 2020 | 411 | 0.140 |
Why?
| | Purines | 1 | 2018 | 33 | 0.140 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2016 | 181 | 0.140 |
Why?
| | Pilot Projects | 1 | 2020 | 726 | 0.140 |
Why?
| | Exosomes | 1 | 2018 | 58 | 0.140 |
Why?
| | Cell Differentiation | 2 | 2026 | 681 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 579 | 0.140 |
Why?
| | Oocyte Retrieval | 1 | 2017 | 5 | 0.130 |
Why?
| | Chemokine CXCL2 | 1 | 2017 | 11 | 0.130 |
Why?
| | Ovulation Induction | 1 | 2017 | 11 | 0.130 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2017 | 6 | 0.130 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2017 | 8 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 630 | 0.130 |
Why?
| | Fatty Liver | 1 | 2018 | 145 | 0.130 |
Why?
| | Parity | 1 | 2017 | 46 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2016 | 392 | 0.130 |
Why?
| | Ideal Body Weight | 1 | 2017 | 6 | 0.130 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1112 | 0.130 |
Why?
| | Friends | 1 | 2017 | 22 | 0.130 |
Why?
| | Organ Size | 2 | 2015 | 226 | 0.130 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 1925 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2017 | 72 | 0.130 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 96 | 0.130 |
Why?
| | Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.120 |
Why?
| | Chemokine CXCL11 | 1 | 2016 | 7 | 0.120 |
Why?
| | Granulosa Cells | 1 | 2016 | 12 | 0.120 |
Why?
| | Versicans | 1 | 2016 | 10 | 0.120 |
Why?
| | Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.120 |
Why?
| | Chemokine CXCL10 | 1 | 2016 | 20 | 0.120 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2016 | 14 | 0.120 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 45 | 0.120 |
Why?
| | Sex Characteristics | 2 | 2018 | 204 | 0.120 |
Why?
| | Receptors, CCR2 | 1 | 2016 | 13 | 0.120 |
Why?
| | Food, Formulated | 2 | 2023 | 41 | 0.120 |
Why?
| | Amino Acids | 1 | 2019 | 382 | 0.120 |
Why?
| | Guidelines as Topic | 1 | 2017 | 111 | 0.120 |
Why?
| | Immunoblotting | 1 | 2016 | 118 | 0.120 |
Why?
| | Chemokine CCL2 | 1 | 2016 | 66 | 0.120 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 1544 | 0.120 |
Why?
| | RNA, Messenger | 2 | 2016 | 1133 | 0.120 |
Why?
| | Phosphoproteins | 1 | 2016 | 117 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2017 | 193 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 171 | 0.120 |
Why?
| | Family | 1 | 2017 | 179 | 0.110 |
Why?
| | Ultrasonography | 2 | 2015 | 426 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 148 | 0.110 |
Why?
| | Tissue Plasminogen Activator | 1 | 2016 | 108 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2017 | 315 | 0.110 |
Why?
| | Premature Birth | 1 | 2017 | 149 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2017 | 330 | 0.110 |
Why?
| | Up-Regulation | 1 | 2016 | 456 | 0.110 |
Why?
| | Autonomic Nervous System | 1 | 2015 | 60 | 0.110 |
Why?
| | Mice | 5 | 2025 | 5982 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 1003 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 591 | 0.100 |
Why?
| | Prognosis | 1 | 2019 | 2118 | 0.100 |
Why?
| | Immunohistochemistry | 1 | 2016 | 975 | 0.100 |
Why?
| | Deuterium Oxide | 1 | 2012 | 10 | 0.100 |
Why?
| | Air | 1 | 2012 | 22 | 0.100 |
Why?
| | Liver | 1 | 2018 | 1150 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 523 | 0.090 |
Why?
| | Bacteria | 3 | 2022 | 226 | 0.090 |
Why?
| | Life Style | 2 | 2023 | 150 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2012 | 96 | 0.090 |
Why?
| | Swine | 2 | 2010 | 440 | 0.090 |
Why?
| | Evoked Potentials, Auditory | 1 | 2011 | 90 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2012 | 867 | 0.080 |
Why?
| | Calibration | 1 | 2010 | 58 | 0.080 |
Why?
| | Genitalia | 1 | 2009 | 10 | 0.080 |
Why?
| | Radionuclide Imaging | 1 | 2010 | 107 | 0.080 |
Why?
| | United States | 2 | 2020 | 5409 | 0.080 |
Why?
| | Anticarcinogenic Agents | 1 | 2009 | 32 | 0.080 |
Why?
| | Phytoestrogens | 1 | 2009 | 23 | 0.080 |
Why?
| | Genistein | 1 | 2009 | 45 | 0.080 |
Why?
| | Cell Line | 2 | 2013 | 1016 | 0.080 |
Why?
| | Biological Availability | 1 | 2009 | 107 | 0.070 |
Why?
| | Flavonoids | 1 | 2009 | 55 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2012 | 1219 | 0.070 |
Why?
| | Species Specificity | 1 | 2009 | 191 | 0.070 |
Why?
| | Gastrointestinal Tract | 1 | 2009 | 110 | 0.070 |
Why?
| | Palmitates | 2 | 2022 | 28 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2026 | 1569 | 0.070 |
Why?
| | Gastrointestinal Diseases | 1 | 2009 | 130 | 0.070 |
Why?
| | Rifabutin | 1 | 2007 | 5 | 0.070 |
Why?
| | Lactams, Macrocyclic | 1 | 2007 | 19 | 0.070 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2007 | 68 | 0.070 |
Why?
| | Benzoquinones | 1 | 2007 | 33 | 0.070 |
Why?
| | Etoposide | 1 | 2007 | 71 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2014 | 547 | 0.070 |
Why?
| | Estradiol | 1 | 2007 | 215 | 0.060 |
Why?
| | Cell Respiration | 1 | 2026 | 49 | 0.060 |
Why?
| | Regression Analysis | 2 | 2017 | 391 | 0.060 |
Why?
| | Body Height | 1 | 2025 | 68 | 0.060 |
Why?
| | Bifidobacterium | 1 | 2024 | 5 | 0.050 |
Why?
| | Mother-Child Relations | 1 | 2024 | 55 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2009 | 1517 | 0.050 |
Why?
| | Language Development | 2 | 2016 | 26 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 122 | 0.050 |
Why?
| | Immune System | 1 | 2024 | 41 | 0.050 |
Why?
| | Food Handling | 1 | 2023 | 15 | 0.050 |
Why?
| | Vitamins | 1 | 2023 | 64 | 0.050 |
Why?
| | Lymphocytes | 1 | 2024 | 146 | 0.050 |
Why?
| | Alkaline Phosphatase | 1 | 2023 | 92 | 0.050 |
Why?
| | Osteocalcin | 1 | 2023 | 45 | 0.050 |
Why?
| | Syndrome | 1 | 2023 | 248 | 0.050 |
Why?
| | Nutritional Status | 1 | 2023 | 148 | 0.050 |
Why?
| | Nutrition Surveys | 1 | 2023 | 118 | 0.050 |
Why?
| | Energy Intake | 1 | 2023 | 186 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2024 | 282 | 0.050 |
Why?
| | Butyrates | 1 | 2022 | 30 | 0.050 |
Why?
| | Gene Expression | 1 | 2024 | 618 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2021 | 28 | 0.050 |
Why?
| | Carnitine | 1 | 2022 | 67 | 0.040 |
Why?
| | Weight Loss | 1 | 2023 | 257 | 0.040 |
Why?
| | RNA, Viral | 1 | 2021 | 123 | 0.040 |
Why?
| | Self Report | 1 | 2022 | 225 | 0.040 |
Why?
| | Phonetics | 2 | 2011 | 41 | 0.040 |
Why?
| | Health Promotion | 1 | 2023 | 278 | 0.040 |
Why?
| | Age Factors | 2 | 2014 | 1136 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 49 | 0.040 |
Why?
| | Optical Imaging | 1 | 2020 | 27 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2020 | 43 | 0.040 |
Why?
| | Transcription Factors | 1 | 2023 | 571 | 0.040 |
Why?
| | CpG Islands | 1 | 2020 | 114 | 0.040 |
Why?
| | Bone and Bones | 1 | 2023 | 501 | 0.040 |
Why?
| | Mental Disorders | 1 | 2024 | 446 | 0.040 |
Why?
| | Language | 1 | 2020 | 147 | 0.040 |
Why?
| | Metagenome | 1 | 2018 | 40 | 0.040 |
Why?
| | Metagenomics | 1 | 2018 | 41 | 0.040 |
Why?
| | Community-Based Participatory Research | 1 | 2020 | 203 | 0.040 |
Why?
| | Biodiversity | 1 | 2018 | 58 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 81 | 0.030 |
Why?
| | Phylogeny | 1 | 2018 | 231 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 910 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 33 | 0.030 |
Why?
| | Myocardium | 1 | 2020 | 471 | 0.030 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 16 | 0.030 |
Why?
| | Thinness | 1 | 2016 | 44 | 0.030 |
Why?
| | Skull | 1 | 2016 | 75 | 0.030 |
Why?
| | Thiazolidinediones | 1 | 2016 | 81 | 0.030 |
Why?
| | Anisotropy | 1 | 2015 | 62 | 0.030 |
Why?
| | Child Language | 1 | 2014 | 10 | 0.030 |
Why?
| | Intelligence Tests | 1 | 2014 | 39 | 0.030 |
Why?
| | Proteins | 1 | 2017 | 351 | 0.030 |
Why?
| | Intelligence | 1 | 2014 | 56 | 0.030 |
Why?
| | Glucose | 1 | 2016 | 361 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2014 | 60 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2014 | 69 | 0.030 |
Why?
| | Culture Media | 1 | 2014 | 97 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 202 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2014 | 88 | 0.030 |
Why?
| | Osteogenesis | 1 | 2016 | 374 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 102 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2014 | 133 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2013 | 8 | 0.030 |
Why?
| | Trophoblasts | 1 | 2013 | 32 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2014 | 345 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 587 | 0.020 |
Why?
| | Serum Response Factor | 1 | 2013 | 45 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 563 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 127 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 1031 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 272 | 0.020 |
Why?
| | Milk Substitutes | 1 | 2010 | 5 | 0.020 |
Why?
| | Speech Acoustics | 1 | 2010 | 19 | 0.020 |
Why?
| | Rats | 1 | 2016 | 3162 | 0.020 |
Why?
| | Diarrhea, Infantile | 1 | 2009 | 5 | 0.020 |
Why?
| | Rotavirus Infections | 1 | 2009 | 6 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2009 | 120 | 0.020 |
Why?
| | Signal Transduction | 1 | 2016 | 1748 | 0.020 |
Why?
| | Testis | 1 | 2009 | 74 | 0.020 |
Why?
| | Uterus | 1 | 2009 | 81 | 0.020 |
Why?
| | Prostate | 1 | 2009 | 118 | 0.020 |
Why?
| | Bone Development | 1 | 2009 | 68 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 357 | 0.020 |
Why?
|
|
Andres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|